详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Cause and consequence of heterogeneity in human mesenchymal stem cells: Challenges in clinical application

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Department of Clinical Laboratory, Xi’an International Medical Center Hospital, Xi’an, Shaanxi, China [2]Assisted Reproductive Center, Women’s & Children’s Hospital of Northwest, Xi’an, Shaanxi, China [3]University of South Bohemia in Ceske Budejovice, Faculty of Fisheries and Protection of Waters, South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Research Institute of Fish Culture and Hydrobiology, Vodnany, Czech Republic [4]Department of Evolution, Ecology and Behaviour, University of Liverpool, Liverpool, UK [5]Medical Center of Hematology, the Second Affiliated Hospital, Army Medical University, Chongqing, Sichuan, China [6]Changsha Medical University, Changsha, Hunan, China

出处：

DOI：

ISSN：

关键词： Mesenchymal stem cells Heterogeneity Cancer therapy

摘要：

Human mesenchymal stem cells (hMSCs) are mesoderm-derived adult stem cells with self-proliferation capacity, pluripotent differentiation potency, and excellent histocompatibility. These advantages make hMSCs a promising tool in clinical application. However, the majority of clinical trials using hMSC therapy for diverse human diseases do not achieve expectations, despite the prospective pre-clinical outcomes in animal models. This is partly attributable to the intrinsic heterogeneity of hMSCs. In this review, the cause of heterogeneity in hMSCs is systematically discussed at multiple levels, including isolation methods, cultural conditions, donor-to-donor variation, tissue sources, intra-tissue subpopulations, etc. Additionally, the effect of hMSCs heterogeneity on the contrary role in tumor progression and immunomodulation is also discussed. The attempts to understand the cellular heterogeneity of hMSCs and its consequences are important in supporting and improving therapeutic strategies for hMSCs.Copyright © 2024 Elsevier GmbH. All rights reserved.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 4 区医学

小类 | 4 区病理学

最新[2023]版：

大类 | 4 区医学

小类 | 4 区病理学

第一作者：

第一作者机构： [1]Department of Clinical Laboratory, Xi’an International Medical Center Hospital, Xi’an, Shaanxi, China

共同第一作者：

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]The Role of Mesenchymal Stem Cells in Cancer Immunotherapy [2]Glioma-associated mesenchymal stem cells [3]Role of T-box genes in cancer, epithelial-mesenchymal transition, and cancer stem cells. [4]Role of T-box genes in cancer, epithelial-mesenchymal transition, and cancer stem cells. [5]Current therapeutic strategies for respiratory diseases using mesenchymal stem cells. [6]Mesenchymal stem cells preserve their stem cell traits after exposure to antimetabolite chemotherapy. [7]骨髓源间充质干细胞注射疗法对肝硬化大鼠模型免疫系统的调节作用及其相关机制研究 [8]间充质干细胞对去除CD4+CD25+调节性T细胞哮喘小鼠气道炎症的影响 [9]Self-oxygenation of engineered living tissues orchestrates osteogenic commitment of mesenchymal stem cells [10]Biomimetic Methacrylated Gelatin Hydrogel Loaded With Bone Marrow Mesenchymal Stem Cells for Bone Tissue Regeneration.